Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study).
Uchida S, Takahashi M, Sugawara M, Saito T, Nakai K, Fujita M, Mochizuki K, Shin I, Morita T, Hikita T, Itakura H, Takahashi Y, Mizuno S, Ohno Y, Ito K, Ito T, Soma M.
Uchida S, et al. Among authors: nakai k.
J Clin Hypertens (Greenwich). 2014 Oct;16(10):746-53. doi: 10.1111/jch.12412. Epub 2014 Sep 29.
J Clin Hypertens (Greenwich). 2014.
PMID: 25264215
Free PMC article.
Clinical Trial.